No, Sickle Cell Disease Is NOT Limited to Black People
Sickle cell disease affects multiple ethnic groups beyond individuals of African descent, including people from the Middle East, India, the Mediterranean region (particularly southern and eastern areas), and the Caribbean. 1
Geographic and Ethnic Distribution
While the majority of patients with sickle cell disease in Western countries are of African or Caribbean background (98% of patients registered in England's National Haemoglobinopathy Registry), this reflects migration patterns rather than exclusive susceptibility 1. The disease is also found in:
- Middle Eastern populations
- Indian subcontinent populations
- Mediterranean populations (southern and eastern regions, including Greek, Turkish, and Italian ancestry)
- Hispanic populations 2
Why This Misconception Exists
The HbS mutation evolved as a protective mechanism against malaria in endemic regions, which explains its higher frequency in sub-Saharan Africa 3. However, malaria has historically affected multiple geographic regions, leading to the same selective pressure maintaining the sickle cell gene in Mediterranean, Middle Eastern, and Asian populations 3.
A critical pitfall: The widespread belief that sickle cell disease only affects African Americans (67.8% of surveyed students held this misconception) leads to missed diagnoses in other ethnic groups 4. This is particularly dangerous because:
- Non-African patients may present differently (Caucasian patients in Italy tend to be older with HbS/β-thalassemia genotypes and more chronic complications rather than acute crises) 5
- Healthcare providers may not consider SCD in their differential diagnosis for non-Black patients
- Screening programs may inadvertently exclude at-risk populations
Clinical Implications
Any patient presenting with unexplained pain, fatigue, anemia, or hemolysis markers should be screened for sickle cell disease regardless of ethnicity 5. The diagnostic approach should include:
- Complete blood count with erythrocyte morphology
- Hemolysis markers
- HPLC assessment of hemoglobin fractions (first-level screening)
If two risk factors are present (family history, ethnicity from endemic regions, or significant clinical features), immediate screening or specialist referral is warranted 5.
Global Perspective
Sickle cell trait (HgS) is present in 8% of Black individuals but also occurs in 0.08% of non-Black populations 6. The disease represents a significant global health burden affecting approximately 100,000 Americans and millions worldwide, with substantial populations in India requiring dedicated management guidelines 7, 8.
The key takeaway: Restricting sickle cell screening or consideration to only Black patients will result in missed diagnoses, delayed treatment, and preventable morbidity and mortality in other affected populations.